Risplom 2T MD Tablet contains a combination of Risperidone 2mg, an atypical antipsychotic, and Trihexyphenidyl 2mg, an anticholinergic agent used to manage extrapyramidal symptoms caused by antipsychotic therapy. This combination is designed for effective management of schizophrenia, bipolar disorder, and other psychotic conditions while reducing side effects like tremors and rigidity.
Risperidone helps in controlling hallucinations, delusions, mood swings, and agitation, whereas Trihexyphenidyl prevents involuntary muscle movements and improves patient comfort.
Belonging to the CNS and psychiatry therapeutic segment, this tablet is widely prescribed by psychiatrists and neurologists, making it a high-demand medicine in hospitals, psychiatric clinics, and institutional pharmacies.
For PCD pharma franchise partners, distributors, and exporters, Risplom 2T MD Tablet offers a valuable business opportunity. It is available for third-party manufacturing, bulk institutional supply, and wholesale distribution with competitive margins and repeat demand across India.